Last reviewed · How we verify

Kangguzengsheng capsule

Guizhou Bailing Group Pharmaceutical Co Ltd · FDA-approved active Small molecule

Kangguzengsheng capsule is a traditional Chinese medicine formulation that promotes bone growth and enhances skeletal development through multiple herbal components.

Kangguzengsheng capsule is a traditional Chinese medicine formulation that promotes bone growth and enhances skeletal development through multiple herbal components. Used for Bone growth promotion and skeletal development support, Bone deficiency and osteoporosis-related conditions.

At a glance

Generic nameKangguzengsheng capsule
Also known asKGZS capsule
SponsorGuizhou Bailing Group Pharmaceutical Co Ltd
ModalitySmall molecule
Therapeutic areaOrthopedics / Bone Health
PhaseFDA-approved

Mechanism of action

This herbal capsule combines traditional Chinese medicinal ingredients believed to strengthen bone metabolism and promote osteoblast activity. The formulation is designed to support bone density and skeletal health, particularly in conditions involving bone deficiency or growth impairment. The exact molecular mechanisms remain consistent with traditional Chinese medicine theory rather than single-target pharmacology.

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: